Development, upscaling and validation of the purification process for human-cl rhFVIII (Nuwiq®), a new generation recombinant factor VIII produced in a human cell-line-Reference-Cited by-同舟云学术

Development, upscaling and validation of the purification process for human-cl rhFVIII (Nuwiq®), a new generation recombinant factor VIII produced in a human cell-line

Published:2015-11 Issue: Volume:115 Page:165-175
ISSN:1046-5928
Container-title:Protein Expression and Purification
language:en
Short-container-title:Protein Expression and Purification

Author:

Winge Stefan,Yderland Louise,Kannicht Christoph,Hermans Pim,Adema Simon,Schmidt Torben,Gilljam Gustav,Linhult Martin,Tiemeyer Maya,Belyanskaya Larisa,Walter Olaf

Publisher

Elsevier BV

Subject

Biotechnology

Reference44 articles.

1. Treatment of hemophilia: a review of current advances and ongoing issues;Coppola;J. Blood Med.,2010

2. The modern treatment of haemophilia: a narrative review;Franchini;Blood Transfus.,2013

3. Effects of haemophilic arthropathy on health-related quality of life and socio-economic parameters;Fischer;Haemophilia,2005

5. The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977–99;Darby;J. Thromb. Haemost.,2004

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upstream and Downstream Processes of rFVIII Recombinant Protein Manufacturing in Respect to Fluid Flow, Mixing, Heat and Mass Transfer;Düzce Üniversitesi Bilim ve Teknoloji Dergisi;2024-07-31

2. Advances and challenges in the purification of recombinant coagulation factors: A review;Journal of Chromatography A;2024-02

3. Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A—Final efficacy and safety results from the NuProtect study;European Journal of Haematology;2023-07-13

4. Purification Process of a Recombinant Human Follicle Stimulating Hormone Biosimilar (Primapur®) to Yield a Pharmaceutical Product with High Batch-to-Batch Consistency;Pharmaceutics;2022-01-01

5. Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study;Thrombosis and Haemostasis;2021-02-13